4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-007489
Chief Reg & Develop Officer gave up 1,114 shares (to pay taxes)
- Chief Reg & Develop Officer acquired 3,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powala Christopher Chief Reg & Develop Officer | 2019-02-01 | Option exercise | +3,400 | 142,843 | D | ||
| Powala Christopher Chief Reg & Develop Officer | 2019-02-01 | Shares withheld for taxes | −1,114 | $6.96 | $7,753 | 141,729 | D |
| Derivatives | |||||||
| Powala Christopher Chief Reg & Develop Officer | 2019-02-01 | Option exercise · Restricted Stock Units | −3,400 | 10,200 | D | ||
Loading xslF345X03/doc4.xml…